• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙炔雌二醇可增加大鼠肝脏多药耐药相关蛋白3(MRP3)的表达及活性。

Ethynylestradiol increases expression and activity of rat liver MRP3.

作者信息

Ruiz María L, Villanueva Silvina S M, Luquita Marcelo G, Vore Mary, Mottino Aldo D, Catania Viviana A

机构信息

Instituto de Fisiología Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Argentina.

出版信息

Drug Metab Dispos. 2006 Jun;34(6):1030-4. doi: 10.1124/dmd.106.009316. Epub 2006 Mar 22.

DOI:10.1124/dmd.106.009316
PMID:16554369
Abstract

We evaluated the effect of ethynylestradiol (EE) administration (5 mg/kg b.wt. s.c., for 5 consecutive days) on the expression and activity of multidrug resistance-associated protein 3 (Mrp3) in rats. Western blotting analysis revealed decreased Mrp2 (-41%) and increased Mrp3 (+200%) expression by EE. To determine the functional impact of up-regulation of Mrp3 versus Mrp2, we measured the excretion of acetaminophen glucuronide (APAP-glu), a common substrate for both transporters, into bile and perfusate in the recirculating isolated perfused liver (IPL) model. APAP-glu was generated endogenously from acetaminophen (APAP), which was administered as a tracer dose (2 micromol/ml) into the perfusate. Biliary excretion of APAP-glu after 60 min of perfusion was reduced in EE-treated rats (-80%). In contrast, excretion into the perfusate was increased by EE (+45%). Liver content of APAP-glu at the end of the experiment was reduced by 36% in the EE group. The total amount of glucuronide remained the same in both groups. Taken together, these results indicate that up-regulation of Mrp3 led to an exacerbated basolateral versus canalicular excretion of conjugated APAP in IPL. We conclude that induced expression of basolateral Mrp3 by EE may represent a compensatory mechanism to prevent intracellular accumulation of common Mrp substrates, either endogenous or exogenous, due to reduced expression and activity of apical Mrp2.

摘要

我们评估了乙炔雌二醇(EE)给药(5毫克/千克体重,皮下注射,连续5天)对大鼠多药耐药相关蛋白3(Mrp3)表达和活性的影响。蛋白质免疫印迹分析显示,EE使Mrp2表达降低(-41%),Mrp3表达增加(+200%)。为了确定Mrp3上调相对于Mrp2上调的功能影响,我们在循环离体灌注肝(IPL)模型中测量了对乙酰氨基酚葡糖醛酸苷(APAP-葡糖醛酸苷)(这两种转运蛋白的常见底物)向胆汁和灌注液中的排泄。APAP-葡糖醛酸苷由对乙酰氨基酚(APAP)内源性生成,APAP作为示踪剂量(2微摩尔/毫升)注入灌注液中。灌注60分钟后,EE处理的大鼠中APAP-葡糖醛酸苷的胆汁排泄减少(-80%)。相反,EE使灌注液中的排泄增加(+45%)。实验结束时,EE组中APAP-葡糖醛酸苷的肝脏含量降低了36%。两组中葡糖醛酸苷的总量保持不变。综上所述,这些结果表明,Mrp3的上调导致IPL中共轭APAP的基底外侧排泄相对于胆小管排泄加剧。我们得出结论,EE诱导基底外侧Mrp3的表达可能代表一种补偿机制,以防止由于顶端Mrp2表达和活性降低而导致内源性或外源性常见Mrp底物在细胞内积累。

相似文献

1
Ethynylestradiol increases expression and activity of rat liver MRP3.乙炔雌二醇可增加大鼠肝脏多药耐药相关蛋白3(MRP3)的表达及活性。
Drug Metab Dispos. 2006 Jun;34(6):1030-4. doi: 10.1124/dmd.106.009316. Epub 2006 Mar 22.
2
Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.螺内酯给药对大鼠乙炔雌二醇诱导的胆汁淤积的有益作用:多药耐药相关蛋白2上调的参与
Drug Metab Dispos. 2007 Nov;35(11):2060-6. doi: 10.1124/dmd.107.016519. Epub 2007 Aug 8.
3
Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats.在胆管结扎的大鼠中,对乙酰氨基酚葡萄糖醛酸苷的肝脏合成及尿液排泄会加剧。
Drug Metab Dispos. 2008 Mar;36(3):475-80. doi: 10.1124/dmd.107.018127. Epub 2007 Dec 20.
4
Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.雌二醇诱导肝多药耐药相关蛋白 3 的表达不依赖于胆汁淤积,并通过雌激素受体介导。
Drug Metab Dispos. 2013 Feb;41(2):275-80. doi: 10.1124/dmd.112.047357. Epub 2012 Oct 17.
5
Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.急性苯巴比妥治疗或苯巴比妥预处理后对乙酰氨基酚葡萄糖醛酸苷胆汁排泄受损的机制。
Drug Metab Dispos. 2002 Sep;30(9):962-9. doi: 10.1124/dmd.30.9.962.
6
Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.对大鼠重复给予亚毒性剂量对乙酰氨基酚对随后毒性剂量药物肝肠循环的影响。
Biochem Pharmacol. 2009 May 15;77(10):1621-8. doi: 10.1016/j.bcp.2009.02.006. Epub 2009 Feb 23.
7
Calculus Bovis Sativus up-regulates hepatic protein 2 (Mrp2) and Mrp4 in 17α-ethynylestradiol-induced cholestasis via a regulatory effect on ER signaling.虫草素通过调节 ER 信号通路上调 17α-乙炔基雌二醇诱导的胆汁淤积中的肝蛋白 2(Mrp2)和 Mrp4。
J Tradit Chin Med. 2019 Jun;39(3):402-409.
8
Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.大鼠中对乙酰氨基酚硫酸盐的胆汁排泄涉及多种机制:多药耐药相关蛋白2(Mrp2)和乳腺癌耐药蛋白1(Bcrp1)的作用。
Drug Metab Dispos. 2005 Aug;33(8):1158-65. doi: 10.1124/dmd.104.002188. Epub 2005 Apr 28.
9
Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.对乙酰氨基酚在Mrp3基因敲除小鼠体内的处置改变。
Hepatology. 2005 Nov;42(5):1091-8. doi: 10.1002/hep.20898.
10
Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.大鼠肝脏中多药耐药蛋白3的诱导与对乙酰氨基酚代谢物的向量排泄改变有关。
Drug Metab Dispos. 2003 Sep;31(9):1176-86. doi: 10.1124/dmd.31.9.1176.

引用本文的文献

1
Quantitative Proteomics Reveals Changes in Transporter Protein Abundance in Liver, Kidney and Brain of Mice by Pregnancy.定量蛋白质组学揭示孕期小鼠肝脏、肾脏和大脑中转运蛋白丰度的变化。
Drug Metab Lett. 2018;12(2):145-152. doi: 10.2174/1872312812666180625122810.
2
Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.雌二醇诱导肝多药耐药相关蛋白 3 的表达不依赖于胆汁淤积,并通过雌激素受体介导。
Drug Metab Dispos. 2013 Feb;41(2):275-80. doi: 10.1124/dmd.112.047357. Epub 2012 Oct 17.
3
Down-regulation of brush border efflux transporter expression in the kidneys of pregnant mice.
下调孕鼠肾脏刷状缘外排转运体的表达。
Drug Metab Dispos. 2013 Feb;41(2):320-5. doi: 10.1124/dmd.112.047092. Epub 2012 Aug 15.
4
Regulation of hepatic ABCC transporters by xenobiotics and in disease states.异生物质和疾病状态对肝脏 ABCC 转运体的调节。
Drug Metab Rev. 2010 Aug;42(3):482-538. doi: 10.3109/03602531003654915.
5
Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.乙炔雌二醇诱导胆汁淤积大鼠中二甲双胍抗糖尿病作用减弱及肝脏有机阳离子转运体1(Oct1)下调
Pharm Res. 2009 Mar;26(3):549-59. doi: 10.1007/s11095-008-9770-5. Epub 2008 Nov 11.